Comparison between Eris Lifesciences IPO and Salasar Techno Engineering IPO.
Eris Lifesciences IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Salasar Techno Engineering IPO is a Mainboard Fixed Price proposed to list at BSE, NSE.
The total issue size of Eris Lifesciences IPO is up to ₹1,740.49 Cr whereas the issue size of the Salasar Techno Engineering IPO is up to ₹35.95 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of Salasar Techno Engineering IPO is ₹108.00 per share.
| Eris Lifesciences IPO | Salasar Techno Engineering IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹600.00 per share | |
| Issue Price (Upper) | ₹603.00 per share | |
| Issue Price (Final) | ₹603.00 per share | ₹108.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹60.00 per share | |
| Market Lot Size | 24 shares | 125 shares |
| Fresh Issue Size | 0 shares | 33,28,964 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹35.95 Cr |
| OFS Issue Size | 2,88,75,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,740.49 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,88,75,000 shares | 33,28,964 shares |
| Issue Size Total (Amount) | up to ₹1,740.49 Cr | up to ₹35.95 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while Salasar Techno Engineering IPO opens on Jul 12, 2017. The closing date of Eris Lifesciences IPO and Salasar Techno Engineering IPO is Jun 20, 2017, and Jul 17, 2017, respectively.
| Eris Lifesciences IPO | Salasar Techno Engineering IPO | |
|---|---|---|
| Anchor Bid Date | Jun 15, 2017 | |
| Issue Open | Jun 16, 2017 | Jul 12, 2017 |
| Issue Close | Jun 20, 2017 | Jul 17, 2017 |
| Basis Of Allotment (Tentative) | Jun 23, 2017 | |
| Initiation of Refunds (Tentative) | Jun 27, 2017 | |
| Credit of Share (Tentative) | Jun 28, 2017 | |
| Listing date (Tentative) | Jun 29, 2017 | Jul 25, 2017 |
| Anchor Lockin End date 1 | Jul 23, 2017 | |
| Anchor Lockin End date 2 | Sep 21, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to Salasar Techno Engineering IPO P/E ratio of .
| Eris Lifesciences IPO | Salasar Techno Engineering IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹8291.25 Cr. | ₹143.39 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Eris Lifesciences IPO Retail Individual Investors (RII) are offered 28,72,500 shares while in Salasar Techno Engineering IPO retail investors are offered 28,72,500 shares. Qualified Institutional Buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and in Salasar Techno Engineering IPO.
| Eris Lifesciences IPO | Salasar Techno Engineering IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,29,26,250 shares | |
| Market Maker Reservation | ||
| QIB | 86,17,500 shares | |
| NII | 43,08,750 shares | 16,60,500 shares |
| RII | 28,72,500 shares | 16,60,500 shares |
| Employee | 1,50,000 shares | |
| Others | ||
| Total | 2,88,75,000 shares | 33,21,000 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas Salasar Techno Engineering IPO subscribed 273.05x.
| Eris Lifesciences IPO | Salasar Techno Engineering IPO | |
|---|---|---|
| QIB (times) | 4.68x | |
| NII (times) | 0.45x | 478.39x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.51x | 58.92x |
| Employee (times) | 0.86x | |
| Other (times) | ||
| Total (times) | 3.29x | 273.05x |
